Analysis of Hims & Hers Q4 2025 results, GLP-1 compounding risks, labs, and the $1.15B Eucalyptus acquisition.

Popular weight-loss drugs, including Ozempic, Wegovy, Trulicity and Mounjaro, produced by independent pharmacy labs, sickened ...

The compounds have exploded in popularity, but big questions about safety and effectiveness are still unresolved.

Demand from patients for obesity medication is unrelenting. So, too, is the battle over who gets to develop and distribute ...

The latest wellness craze involves injecting these molecules for athletic performance, longevity and more. Scientists say the ...

Make sure the clinician knows what other medications you’re taking, and set up a real follow-up plan to adjust these ...

The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...

Indiana lawmakers are weighing new guardrails around drug compounding amid warnings that patients are receiving powerful prescription treatments in settings that operate largely outside state ...

Customizing medications can be lifesaving and also dangerous. Understand the advantages and disadvantages of Compounding Pharmacies.

Learn how the proposed bill HB4036 in Arizona could restrict access to compounded medications, impacting patient care and ...

Feb 10 (Reuters) - Novo Nordisk's U.S. patent lawsuit against Hims & Hers, filed on Monday, ‌marks a new front in the Danish pharmaceutical drugmaker's ‌campaign against companies selling compounded ...